Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Caroline H. Williams-Gray
Based on 39 articles published since 2008
||||
Expertise Level
The expertise of Caroline H. Williams-Gray ranks in the
  • Top 0.62%
  • ... of 69,482 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2019
  • ... based on contributions to 39 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Williams-Gray, Caroline   ·   Williams-Gray, Caroline H   ·   Williams-Gray, C   ·   Williams-Gray, C H
Work Locations
Details
Most likely:    University of Cambridge      
2018
  • John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Cambridge, CB2 0PY, UK. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Cambridge, CB2 0PY, UK. · Neurology Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Pubmed 29807534
  • John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, UK. · Pubmed 29633419
2017
  • Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. · Université Pierre et Marie Curie Paris 06 UMR S 1127, Sorbonne Université, Institut du Cerveau et de la Moelle Epinière, Paris, France; U 1127 and Centre d'Investigation Clinique 1422, Institut National de Santé et en Recherche Médicale, Paris, France; U 7225, Centre National de Recherche Scientifique, Paris, France; Département de Neurologie et de Génétique, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France. · Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, Netherlands; German Center for Neurodegenerative diseases, Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · San Francisco Veterans Affairs Medical Center and Department of Neurology, UCSF School of Medicine, San Francisco, CA, USA. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto, Toronto, ON, Canada. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, University Paris-Sud, UMRS 1018, Villejuif, France. · Voyager Therapeutics, Cambridge, MA, USA. · Program for Regulatory Science and Medicine, Department of Neurology, Georgetown University, Washington, DC, USA. · Department of Neurology, Leiden University Medical Center, Leiden, Netherlands. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. Electronic address: · Pubmed 28629879
  • Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK. · Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. · John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK. · School of Medicine & Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia. · School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia. · Pubmed 28250029
2016
  • Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK. · Pubmed 26750431
  • Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham & Women's Hospital, Cambridge, MA. · Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA. · Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA. · Department of Neurology, Massachusetts General Hospital, Boston, MA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, The Netherlands. · German Center for Neurodegenerative diseases (DZNE), Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, Villejuif, France. · University Paris-Sud, UMRS 1018, Villejuif, France. · Sorbonne Université, Université Pierre et Marie Curie Paris 06 UMR S 1127, Institut National de Santé et en Recherche Médicale U 1127 and Centre d'Investigation Clinique 1422, Centre National de Recherche Scientifique U 7225, Institut du Cerveau et de la Moelle Epinière, Assistance Publique Hôpitaux de Paris, Département de Neurologie et de Génétique, Hôpital Pitié-Salpêtrière, Paris, France. · Voyager Therapeutics, Clinical Development, Cambridge, MA. · Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 27717005
  • John van Geest Centre for Brain Repair and Department of Clinical Neuroscience, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0PY, United Kingdom. Electronic address: · John van Geest Centre for Brain Repair and Department of Clinical Neuroscience, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0PY, United Kingdom; Department of Biomedical Engineering, Rutgers University, Piscataway, NJ, United States. · John van Geest Centre for Brain Repair and Department of Clinical Neuroscience, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0PY, United Kingdom. · Cambridge Advanced Imaging Centre, Department of Physiology, Development and Neuroscience, Anatomy Building, University of Cambridge, Downing Street, Cambridge CB2 3DY, United Kingdom. · Department of Biomedical Engineering, Rutgers University, Piscataway, NJ, United States; Department of Chemical & Biochemical Engineering, Rutgers University, Piscataway, NJ, United States. · John van Geest Centre for Brain Repair and Department of Clinical Neuroscience, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0PY, United Kingdom; Department of Neurology, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom. · Pubmed 27632900
  • Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK. · Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. · John van Geest Centre for Brain Repair, University of Cambridge, UK. · School of Medicine & Menzies Health Institute Queensland, Griffith University, Australia. · Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK. Electronic address: · Pubmed 27094482
  • Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Division of Life Science, Hong Kong University of Science and Technology, Hong Kong Special Administrative Region, China. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Genetics and Epigenetics of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), Tübingen, Germany; Genetics and Epigenetics of Neurodegeneration, Tübingen, Germany. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, Cardiff, UK; Medical Genetics and Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, Cardiff, UK. · Reta Lila Weston Institute for Neurological Studies, UCL Institute of Neurology, London, UK; Department of Regional Neurosciences, Royal Victoria Hospital, Belfast, UK. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Reta Lila Weston Institute for Neurological Studies, UCL Institute of Neurology, London, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK. · John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, Forvie Site, University of Cambridge, Cambridge, UK. · Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, Netherlands. · Genome Biology of Neurodegenerative Diseases, Tübingen, Germany. · Research Unit U1127 at INSERM, Research Unit UMR 7225 at the French National Center for Scientific Research (CNRS), and Research Unit UMR_S 1127 at Pierre and Marie Curie University University of Paris VI at Sorbonne Universités, Institut du Cerveau et de la Moelle épinière Brain and Spine Institute (ICM), Paris, France; Clinical Investigation Center Unit 1422 at INSERM and AP-HP Hôpital de la Pitié Salpêtrière, Centre d'Investigation Clinique Pitié Neurosciences, Paris, France. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research (HIH), Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Department of Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany. · Sobell Department of Motor Neuroscience, UCL Institute of Neurology, London, UK. · Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. · School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK. · Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. · Reta Lila Weston Institute for Neurological Studies, UCL Institute of Neurology, London, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · UCL Genetics Institute, London, UK. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, Cardiff, UK. Electronic address: · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. Electronic address: · Pubmed 27017469
  • John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Institute of Neuroscience, Newcastle University, Newcastle, UK. · Medicine for the Elderly, Western General Hospital, Edinburgh, UK. · School of Medicine, Griffith University, Australia. · Pubmed 26999434
  • From the Department of Neurology (D.C.V., R.M.A.d.B., L.W.), Department of Medical Psychology (B.S.), and Clinical Research Unit (R.J.d.H.), Academic Medical Center, Amsterdam, the Netherlands · John Van Geest Centre for Brain Repair (J.R.E., S.L.M., R.A.B., C.H.W.-G.), Department of Clinical Neurosciences, University of Cambridge · Institute of Neurology (T.F.), University College London, UK · Department of Brain and Cognition (B.S.), University of Amsterdam · and Department of Neurology (B.P.), Radboud University Medical Center, Nijmegen, the Netherlands. · Pubmed 26888991
  • John Van Geest Center for Brain Repair, University of Cambridge, UK, Cambridge, UK. · Pubmed 26688186
2015
  • Critical Path Institute, CAMD, Tucson, AZ, USA. · Nuffield Department of Clinical Neurosciences, University of Oxford, Neurology Department, Level 3, West Wing, John Radcliffe Hospital, Headley Way, Headington, Oxford, UK. · Scientific consultant, London, UK. · Henry Wellcome Building, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. · University of Bristol, Canynge Hall, Bristol, UK. · US Food and Drug Administration (FDA), New Hampshire Avenue, Silver Spring, MD, USA. · EMA, 30 Churchill Place, Canary Wharf, London, UK. · U of Rochester Medical Center, Crittenden Blvd, Rochester, NY, USA. · Michael J Fox Foundation for Parkinson's Research, Seventh Avenue, New York, NY, USA. · Aston University and MIT, Aston University, Aston Triangle, Birmingham, Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA. · Sage Bionetworks, Seattle, WA, USA. · Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK Department of Neurology, Royal Free Hospital, London, UK Neurology, National Hospital for Neurology, London, UK. · Institute of Neuroscience and Psychology, University of Glasgow, Scotland, UK. · National Institute of Neurological Disorders and Stroke (NINDS), Neuroscience Center, Bethesda, MD, USA. · Department of Psychiatry, University of Oxford Hospital, Warneford, Oxford, UK. · Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, UK. · Independent Scientific & Medical Writer, Savits Drive, Elverson, PA, USA. · Institute of Neurodegenerative Diseases, Parkinson's Progression Markers Initiative, Suite 8B, New Haven, CT, USA. · Laboratory of Neuro Imaging, Keck School of Medicine of USC, University of Southern California, CA, USA. · Teva Pharmaceutical Industries Ltd., Petach Tikva, Israel. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Parkinson's UK, London, UK. · Pubmed 26406139
  • John Van Geest Center for Brain Repair, University of Cambridge, UK, Cambridge, UK. · Pubmed 26227159
2014
  • John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Pubmed 25147139
  • John Van Geest Centre for Brain Repair, University of Cambridge, Forvie Site, Robinson Way, Cambridge, UK. · John Van Geest Centre for Brain Repair, University of Cambridge, Forvie Site, Robinson Way, Cambridge, UK Department of Neurology, Addenbrooke's Hospital, Cambridge, UK. · Pubmed 25170676
2013
  • John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Pubmed 23781007
2009
  • Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK. · Pubmed 19812213
  • Cambridge Centre for Brain Repair, Dept. of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 2PY, UK. · Pubmed 19308307
2008
  • Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 2PY, UK. · Pubmed 18178571
2013
  • Centre for Brain Repair, University of Cambridge, ED Adrian Building, Forvie Site, Robinson Way, Cambridge CB2 0PY, UK. · Pubmed 23184153
2012
  • Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom. · Pubmed 22733390
  • Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Pubmed 22102531
2011
  • Cambridge Centre for Brain Repair, University of Cambridge, UK. · Pubmed 23939258
  • Cambridge Centre for Brain Repair, University of Cambridge, Cambridge, UK. · Pubmed 21593513
2010
  • Department of Clinical Neurosciences (Cambridge Centre for Brain Repair), University of Cambridge, Cambridge, UK. · Pubmed 20462916
  • University of Cambridge, Department of Clinical Neurosciences, Cambridge, UK. · Pubmed 18755526
2008
  • University of Cambridge Department of Clinical Neurosciences, Cambridge, CB2 7EF, UK. · Pubmed 18577547
Probable:    University College London      
2016
  • Department of Neurology, Queens Medical Centre, Nottingham, UK John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK. · John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK. · John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK Institute of Neurology, London, UK. · Cambridge Institute of Public Health, Cambridge, UK. · Institute of Neurology, London, UK. · Pubmed 26800710
2009
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 39 total) written by Caroline H. Williams-Gray about Parkinson Disease:

  • The motor and cognitive features of Parkinson's disease in patients with concurrent Gaucher disease over 2 years: a case series. 2018
  • Abnormalities of age-related T cell senescence in Parkinson's disease. 2018
  • Targeting Aged Astrocytes May Be a New Therapeutic Strategy in Parkinson's Disease. 2018
  • Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. 2017
  • Stability of mild cognitive impairment in newly diagnosed Parkinson's disease. 2017
  • Review: The spectrum of clinical features seen with alpha synuclein pathology. 2016
  • Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's. 2016
  • α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function. 2016
  • Cognitive decline and quality of life in incident Parkinson's disease: The role of attention. 2016
  • Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data. 2016
Show List of Full Article Records
Google Searches

Learn more about Caroline H. Williams-Gray using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Cambridge
University College London
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Cambridge
2018
  • John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Cambridge, CB2 0PY, UK. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Cambridge, CB2 0PY, UK. · Neurology Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Pubmed 29807534
  • John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, UK. · Pubmed 29633419
2017
  • Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. · Université Pierre et Marie Curie Paris 06 UMR S 1127, Sorbonne Université, Institut du Cerveau et de la Moelle Epinière, Paris, France; U 1127 and Centre d'Investigation Clinique 1422, Institut National de Santé et en Recherche Médicale, Paris, France; U 7225, Centre National de Recherche Scientifique, Paris, France; Département de Neurologie et de Génétique, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France. · Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, Netherlands; German Center for Neurodegenerative diseases, Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · San Francisco Veterans Affairs Medical Center and Department of Neurology, UCSF School of Medicine, San Francisco, CA, USA. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto, Toronto, ON, Canada. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, University Paris-Sud, UMRS 1018, Villejuif, France. · Voyager Therapeutics, Cambridge, MA, USA. · Program for Regulatory Science and Medicine, Department of Neurology, Georgetown University, Washington, DC, USA. · Department of Neurology, Leiden University Medical Center, Leiden, Netherlands. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. Electronic address: · Pubmed 28629879
  • Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK. · Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. · John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK. · School of Medicine & Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia. · School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia. · Pubmed 28250029
2016
  • Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK. · Pubmed 26750431
  • Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham & Women's Hospital, Cambridge, MA. · Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA. · Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA. · Department of Neurology, Massachusetts General Hospital, Boston, MA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, The Netherlands. · German Center for Neurodegenerative diseases (DZNE), Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, Villejuif, France. · University Paris-Sud, UMRS 1018, Villejuif, France. · Sorbonne Université, Université Pierre et Marie Curie Paris 06 UMR S 1127, Institut National de Santé et en Recherche Médicale U 1127 and Centre d'Investigation Clinique 1422, Centre National de Recherche Scientifique U 7225, Institut du Cerveau et de la Moelle Epinière, Assistance Publique Hôpitaux de Paris, Département de Neurologie et de Génétique, Hôpital Pitié-Salpêtrière, Paris, France. · Voyager Therapeutics, Clinical Development, Cambridge, MA. · Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 27717005
  • John van Geest Centre for Brain Repair and Department of Clinical Neuroscience, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0PY, United Kingdom. Electronic address: · John van Geest Centre for Brain Repair and Department of Clinical Neuroscience, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0PY, United Kingdom; Department of Biomedical Engineering, Rutgers University, Piscataway, NJ, United States. · John van Geest Centre for Brain Repair and Department of Clinical Neuroscience, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0PY, United Kingdom. · Cambridge Advanced Imaging Centre, Department of Physiology, Development and Neuroscience, Anatomy Building, University of Cambridge, Downing Street, Cambridge CB2 3DY, United Kingdom. · Department of Biomedical Engineering, Rutgers University, Piscataway, NJ, United States; Department of Chemical & Biochemical Engineering, Rutgers University, Piscataway, NJ, United States. · John van Geest Centre for Brain Repair and Department of Clinical Neuroscience, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0PY, United Kingdom; Department of Neurology, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom. · Pubmed 27632900
  • Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK. · Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. · John van Geest Centre for Brain Repair, University of Cambridge, UK. · School of Medicine & Menzies Health Institute Queensland, Griffith University, Australia. · Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK. Electronic address: · Pubmed 27094482
  • Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Division of Life Science, Hong Kong University of Science and Technology, Hong Kong Special Administrative Region, China. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Genetics and Epigenetics of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), Tübingen, Germany; Genetics and Epigenetics of Neurodegeneration, Tübingen, Germany. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, Cardiff, UK; Medical Genetics and Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, Cardiff, UK. · Reta Lila Weston Institute for Neurological Studies, UCL Institute of Neurology, London, UK; Department of Regional Neurosciences, Royal Victoria Hospital, Belfast, UK. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Reta Lila Weston Institute for Neurological Studies, UCL Institute of Neurology, London, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK. · John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, Forvie Site, University of Cambridge, Cambridge, UK. · Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, Netherlands. · Genome Biology of Neurodegenerative Diseases, Tübingen, Germany. · Research Unit U1127 at INSERM, Research Unit UMR 7225 at the French National Center for Scientific Research (CNRS), and Research Unit UMR_S 1127 at Pierre and Marie Curie University University of Paris VI at Sorbonne Universités, Institut du Cerveau et de la Moelle épinière Brain and Spine Institute (ICM), Paris, France; Clinical Investigation Center Unit 1422 at INSERM and AP-HP Hôpital de la Pitié Salpêtrière, Centre d'Investigation Clinique Pitié Neurosciences, Paris, France. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research (HIH), Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Department of Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany. · Sobell Department of Motor Neuroscience, UCL Institute of Neurology, London, UK. · Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. · School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK. · Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. · Reta Lila Weston Institute for Neurological Studies, UCL Institute of Neurology, London, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · UCL Genetics Institute, London, UK. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, Cardiff, UK. Electronic address: · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. Electronic address: · Pubmed 27017469
  • John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Institute of Neuroscience, Newcastle University, Newcastle, UK. · Medicine for the Elderly, Western General Hospital, Edinburgh, UK. · School of Medicine, Griffith University, Australia. · Pubmed 26999434
  • From the Department of Neurology (D.C.V., R.M.A.d.B., L.W.), Department of Medical Psychology (B.S.), and Clinical Research Unit (R.J.d.H.), Academic Medical Center, Amsterdam, the Netherlands · John Van Geest Centre for Brain Repair (J.R.E., S.L.M., R.A.B., C.H.W.-G.), Department of Clinical Neurosciences, University of Cambridge · Institute of Neurology (T.F.), University College London, UK · Department of Brain and Cognition (B.S.), University of Amsterdam · and Department of Neurology (B.P.), Radboud University Medical Center, Nijmegen, the Netherlands. · Pubmed 26888991
  • John Van Geest Center for Brain Repair, University of Cambridge, UK, Cambridge, UK. · Pubmed 26688186
2015
  • Critical Path Institute, CAMD, Tucson, AZ, USA. · Nuffield Department of Clinical Neurosciences, University of Oxford, Neurology Department, Level 3, West Wing, John Radcliffe Hospital, Headley Way, Headington, Oxford, UK. · Scientific consultant, London, UK. · Henry Wellcome Building, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. · University of Bristol, Canynge Hall, Bristol, UK. · US Food and Drug Administration (FDA), New Hampshire Avenue, Silver Spring, MD, USA. · EMA, 30 Churchill Place, Canary Wharf, London, UK. · U of Rochester Medical Center, Crittenden Blvd, Rochester, NY, USA. · Michael J Fox Foundation for Parkinson's Research, Seventh Avenue, New York, NY, USA. · Aston University and MIT, Aston University, Aston Triangle, Birmingham, Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA. · Sage Bionetworks, Seattle, WA, USA. · Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK Department of Neurology, Royal Free Hospital, London, UK Neurology, National Hospital for Neurology, London, UK. · Institute of Neuroscience and Psychology, University of Glasgow, Scotland, UK. · National Institute of Neurological Disorders and Stroke (NINDS), Neuroscience Center, Bethesda, MD, USA. · Department of Psychiatry, University of Oxford Hospital, Warneford, Oxford, UK. · Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, UK. · Independent Scientific & Medical Writer, Savits Drive, Elverson, PA, USA. · Institute of Neurodegenerative Diseases, Parkinson's Progression Markers Initiative, Suite 8B, New Haven, CT, USA. · Laboratory of Neuro Imaging, Keck School of Medicine of USC, University of Southern California, CA, USA. · Teva Pharmaceutical Industries Ltd., Petach Tikva, Israel. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Parkinson's UK, London, UK. · Pubmed 26406139
  • John Van Geest Center for Brain Repair, University of Cambridge, UK, Cambridge, UK. · Pubmed 26227159
2014
  • John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Pubmed 25147139
  • John Van Geest Centre for Brain Repair, University of Cambridge, Forvie Site, Robinson Way, Cambridge, UK. · John Van Geest Centre for Brain Repair, University of Cambridge, Forvie Site, Robinson Way, Cambridge, UK Department of Neurology, Addenbrooke's Hospital, Cambridge, UK. · Pubmed 25170676
2013
  • John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Pubmed 23781007
2009
  • Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK. · Pubmed 19812213
  • Cambridge Centre for Brain Repair, Dept. of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 2PY, UK. · Pubmed 19308307
2008
  • Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 2PY, UK. · Pubmed 18178571
2013
  • Centre for Brain Repair, University of Cambridge, ED Adrian Building, Forvie Site, Robinson Way, Cambridge CB2 0PY, UK. · Pubmed 23184153
2012
  • Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom. · Pubmed 22733390
  • Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Pubmed 22102531
2011
  • Cambridge Centre for Brain Repair, University of Cambridge, UK. · Pubmed 23939258
  • Cambridge Centre for Brain Repair, University of Cambridge, Cambridge, UK. · Pubmed 21593513
2010
  • Department of Clinical Neurosciences (Cambridge Centre for Brain Repair), University of Cambridge, Cambridge, UK. · Pubmed 20462916
  • University of Cambridge, Department of Clinical Neurosciences, Cambridge, UK. · Pubmed 18755526
2008
  • University of Cambridge Department of Clinical Neurosciences, Cambridge, CB2 7EF, UK. · Pubmed 18577547
Unspecified
2018
  • John Van Geest Centre for Brain Repair, Cambridge, UK. · John Van Geest Centre for Brain Repair, Cambridge, UK. · Lysosomal Disorders Unit, Department of Medicine, Addenbrooke's hospital, University of Cambridge, Cambridge, UK. · Pubmed 29845374
2013
  • Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, Forvie Site, Robinson Way, Cambridge CB2 0PY, UK. · Pubmed 23413260
University College London
2016
  • Department of Neurology, Queens Medical Centre, Nottingham, UK John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK. · John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK. · John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK Institute of Neurology, London, UK. · Cambridge Institute of Public Health, Cambridge, UK. · Institute of Neurology, London, UK. · Pubmed 26800710
2009
8 Other Locations Show
Yearly article counts 032922542442
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.